Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND6 pseudogene 15 (MTND6P15) is a pseudogene, meaning it is a DNA sequence that resembles a known gene—MT-ND6, which encodes a mitochondrial complex I subunit—but is nonfunctional and does not encode a protein[3]. It is not known to have any biological activity, function, or disease association. As a pseudogene, it is not considered a therapeutic target, nor does it interact with drugs or serve as a disease biomarker. MTND6P15 should not be confused with the functional *MT-ND6* gene, which is critical for mitochondrial respiration and is implicated in disorders such as Leber hereditary optic neuropathy and Leigh syndrome[1][2]. There are no established links between MTND6P15 and specific cellular functions, disease mechanisms, or therapeutic interventions. If you are seeking information about a functional therapeutic target, you may want to refer to the MT-ND6 gene or protein, not its pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND6 pseudogene 15 (MTND6P15).